INTRODUCTION
In 1966, Moloney isolated a sarcoma virus (Mo-MuSV) from an intramuscular tumour induced in BALB/c mice after injection with high titres of Moloney murine leukaemia virus (Mo-MuLV) (Moloney, 1960) . Although this virus induced rhabdomyosarcoma when injected intramuscularly (i.m.) in newborn mice and was lethal (Moloney, 1966) , the tumour in the adults was found to regress. Mo-MuSV is a defective virus (Hartley & Rowe, 1966) and requires the aid of a helper virus, usually Mo-MuLV, for its replication. The helper virus alone when injected intravenously (i.v.) or intraperitoneally (i.p.) induces lymphoid leukaemias in adult mice within a period of 6 to 7 months (Gross, 1970; Jolicoeur et al., 1978) .
During the past several years, a number of different isolates of Mo-MuSV have been obtained and molecularly cloned (Vande Woude et al., 1979; Verma et aL, 1980) . The only virus isolate known to induce a blood disease in vivo while retaining its sarcomatogenous activity in newborn mice is the myeloproliferative sarcoma virus (MPSV) (Le Bousse- . Thus i.v. or i.p. injection of MPSV into adult DBA/2 mice induces a myeloproliferative disease associated with a tumoural syndrome. The myeloproliferative disease is characterized by splenomegaly, haematopoietic metaplasia in spleen and liver, myeloma, thrombocytopenia and fibrosis of spleen and bone marrow. The tumoural syndrome, i.e. the presence of nodules with tumour-like morphology, is first observed in haematopoietic organs (spleen, liver, thymus) and then in nonhaematopoietic organs, particularly in the peritoneal membrane (Le Bousse- .
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The number of haematopoietic stem cells was found to be increased in the spleens of mice injected with MPSV. This is particularly true of cells committed to granulo-macrophage differentiation (GM-CFC), whose concentration in the spleen increases about tenfold and the absolute cell number is multiplied by a factor of 100 (Klein et al., 1981) . Finally, this neoplasm is characterized by the presence of GM-CFC whose proliferation as well as differentiation in vitro does not require exogenous colony-stimulating factor (GM-CFC CSF-) (Klein et al., 1982) .
The 78A 1 (A22) isolate of Mo-MuSV was obtained from transformed embryogenic cells of Wistar rats infected with the original Mo-MuSV/Mo-MuLV complex (Bernard et al., 1967) . It was shown that these cells produced a virus that transformed fibroblasts in vitro and induced sarcoma when injected i.m. into newborn mice (Bernard et al., 1967 (Bernard et al., , 1972 . The 78A1 virus hybridizes with v-mos-specific sequences of Mo-MuSV (Devaux et al., 1982) .
We have described the molecular cloning of this new isolate of Mo-MuSV (Devaux et al., 1985) and have shown that its genome is larger than that of other known isolates of Mo-MuSV and is very close in size to that of MPSV. In order to correlate the acquisition of a new haematopoietic tropism by a Mo-MuSV with genomic modifications, we attempted to find out if the 78A1 virus, like MPSV, affected haematopoiesis in sensitive mice. We also compared the biological activity of 78A 1 with that of another sarcoma virus, HT 1, isolated from the same MoMuSV/Mo-MuLV complex, whose genome is only 200 bases shorter than that of the 78A1 virus. Finally, in order to distinguish the properties unique to the sarcoma virus from those of the associated helper virus, we also investigated the biological activity of the cloned helper virus Mo-MuLV (clone pMov-3) injected alone.
We show that 78A1 virus but not the HT1 virus has acquired, like MPSV, the capacity to induce splenomegaly resulting from the proliferation of tumoural nodules and GM-CFC CSF-.
METHODS
Mice. Inbred pathogen-free 3-week-olcl DBA/2 mice were supplied by Iffa-Credo (Institut M~rienx, France) and were free of reovirus and Sendai virus.
Virus. All the viruses used in this study were prepared from cloned cell lines obtained after transfection of NIH-3T3 cells with the corresponding molecularly cloned proviral DNA. Plasmid pMov-3, containing an infectious Mo-MuLV provirus, was a kind gift from Dr R. Jaenisch; HTI was provided by Dr G. F. Vande Woude; A22, a recombinant clone containing the 78A1 Mo-MuSV provirus is described in the accompanying paper.
The defective HTI and 78A1 strains of Mo-MuSV were rescued with Mo-MuLV helper virus (pMov-3) and concentrated supernatants from the transfected murine cell lines were prepared as previously described (Ostertag et al., 1980) . On day 0, viral suspensions were injected intravenously into groups of 15 mice at 4 × 10 ~ f.f.u. (Bilello et al., 1974) per mouse for 78A1, 6 × 105 f.f.u, for HT1. For the Mo-MuLV helper virus, the concentration used corresponded to that required to obtain l06 to 107 foci on FG-10 cells. A group of 15 uninfected DBA/2 mice was used as control.
In vivo studies. Groups of three or four infected and normal control mice were sacrificed after virus infection at different times up to the time at which death occurred due to the infection. At autopsy, the femur, spleen, liver and thymus were removed, weighed and fixed with buffered formalin for histological study. When infected mice developed tumours, they were also removed and fixed for histological studies. Histological sections were stained with haematoxylin-eosin and a specific histological reaction was also performed to detect reticulin fibres.
The number of nucleated cells in the blood and in the femoral bone marrow was determined as described (Le Bousse- and haematocrit readings were made in heparinized capillary tubes.
GM-CFC assay. G ranulo-macrophagic progenitors were cultured in semi-solid medium as described (Klein et al., i981) . Briefly, bone marrow or spleen cells were plated in 35 mm Falcon culture dishes containing 1 ml of a mixture composed of alpha medium, 0.8 ~ metbylcellulose (Fluka-Coyer, France), 25~ horse serum (Seromed, Munich, F.R.G.) and 5% mouse lung-conditioned medium as a source of CSF. Four replicate cultures were prepared for each cell suspension and were incubated at 37 °C in a humidified atmosphere of 5~ CO: in air for 7 days.
Long-term bone marrow culture. Cultures were prepared as described by Dexter et al. (1977) . Briefly, bone marrow cells were flushed from a femur into a 25 cm 2 flask containing 5 ml of Dulbecco's medium supplemented with 10~ foetal calf serum, 10~ horse serum and 10 o M-hydrocortisone. The cultures were maintained at 37 °C in 5~ CO, and fed weekly, with half the culture medium replaced by fresh medium. After 3 weeks, cultures were infected with different viruses. Four flasks were inoculated with isolate HT1, four others with isolate 78A1 (clone A22) and four flasks were kept as controls. The cultures were subsequently fed as described above. The cells which were collected with the harvested medium were washed and assayed for GM-CFC.
RESULTS

In vivo studies
The first clinical signs of the disease induced in DBA/2 mice by the 78A 1 isolate of Mo-MuLV appeared 3 months after i.v. injection and the infected mice died 1 to 2 months later with hind leg paralysis (in 80 to 100~o of infected mice).
An appreciable tumoural syndrome appeared first, since we observed the appearance of tumour masses (200 to 500 mg) in the femoral muscles in 70~ of 78Al-infected mice 3 months after i.v. injection. At this stage of the disease, the spleen was not yet involved. One month later, however, we observed a 10-to 15-fold increase in spleen weight, reaching 1000 to 1500 mg within 4 months after virus infection (Table 1 ). This enlarged spleen had the same macroscopic aspect as the spleen of MPSV-infected mice, i.e. pale and hard. Histologically, splenic structure was profoundly modified by a hyperplasia involving primarily myeloid haematopoietic cell lines and by the appearance of tumoural nodules around centrolobular arterioles of the lymphoid follicles as well as under the splenic capsula. These nodules were composed of fibroblasts, granulocytes, lymphocytes and large blast cells. They also invaded the liver, where haematopoietic metaplasia was observed in vein sinuses and around the portal tract, as well as non-haematopoietic organs, such as muscles, lungs, genitals and the peritoneal membrane. From their localization and their cellular composition, these nodules appeared similar to those described in MPSV-induced neoplasia (Le Bousse- .
In the peripheral blood of the 78Al-infected mice, we observed severe anaemia, since haematocrit values decreased from 40 to 45 ~ in controls to 20 ~ in infected mice. The number of nucleated cells per mm 3 increased slightly from 2000 in normal mice to 15 000 cells in infected animals 5 months after viral infection (Table 1) . This leukocytosis was due primarily to a granulocytosis with the absence of any blasts.
Cell number per femur decreased from 107 to 3 x 106 in the bone marrow of mice having neoplasms (Table 1) . Histologically, this aplasia seemed to be correlated with an increase in the proportion of fat cells. However, we did not detect an increase of the reticulin network as was described in the case of MPSV-infected mice.
In HTl-infected mice, we did not detect any particular clinical modification until 6 months after i.v. virus injection. The only pathological modification observed in Mo-MuLV-infected mice was the appearance of a typical lymphoid leukaemia, 7 months after injection, as already described in the case of Mo-MuLV infection. 
Study of the granulocytic precursors
The study of granulocytic precursors showed that the 78A1 virus induced a fivefold decrease in the number of GM-CFC per femur at the terminal stage of the disease, that is 5 months after infection (Table 2 ). This reduction in the number of GM-CFC per femur is due both to a decrease in their concentration (by a factor of two) and of the femoral cell number. The splenic concentration of G M-CFC increased by a factor of five in mice infected either by 78A 1, HT 1 or Mo-MuLV viruses. Spleen weight of 78Al-infected mice increased by a factor of 10 to 15 and therefore the total number of GM-CFC per spleen increased 7-5-fold in comparison with HT1-or Mo-MuLV-infected mice and increased 50-to 75-fold in comparison with normal mice. Furthermore, we detected 30~ to 50~ of GM-CFC CSF-only in the spleen of 78Al-infected mice (Table 2 ).
In vitro injection of long-term bone marrow cultures
The 78A1 (A22) isolate of Mo-MuSV inoculated in long-term bone marrow cultures inhibits the proliferation of haematopoietic cells. In control and infected cultures, the number of nucleated cells per flask decreased progressively during the 4 weeks of observation (Table 3 ).
The decrease observed in cultures infected with 78A1 (A22) was greater in comparison to controls: at 4 weeks after infection, we could count only 2 x 105 nucleated cells in these cultures, representing 16% of controls.
In cultures infected with the HT1 isolate, at 3 weeks after infection the number of granulomacrophagic progenitors was the same as in control cultures. At 4 weeks, this number decreased to 27% of controls. However, in 78A1 (A22)-infected cultures, the GM-CFC number was lower than in controls as early as the first week after infection. Four weeks later, this number was lower than in HTl-infected cultures: 5% of controls (Table 3) .
DISCUSSION
Studies of the biological activities of the two Mo-MuSV cloned isolates, 78A 1 and HT 1, have shown that only the former caused pathological changes when injected i.v. in 3-week-old mice. Six months after the injection of HT1 virus, the mice exhibited no clinical signs, in particular no tumoural syndrome was observed. Mice infected with 78A 1, in contrast, presented a tumoural syndrome, as well as haematological modifications similar to some of the disorders induced by MPSV. However, the time required for the appearance of pathological effects caused by the 78A 1 virus was rather long, since the first clinical signs of the tumoural syndrome were observed around 3 months after infection. This is quite distinct from the effects of MPSV, which are very rapid and even immediate, since MPSV-specific changes are found within 5 days after infection (Klein et al., 1982) . This difference in the length of latency between the 78A1 virus and MPSV does not seem to be related to the quantity of virus particles injected into the mice, since the titre (in f.f.u.) of the two viruses was identical in related experiments. Similarly, it does not appear that the Jack of pathological activity of HTI virus in vivo was due to an insufficient viral titre, since that of HT1 was 10 times higher than that of 78A1.
Mice infected with the 78A 1 virus exhibited a tumoural syndrome similar to that described in MPSV-induced neoplasia (Le Bousse- . The tumour nodules observed in 78A1 mice were similar to those in MPSV-infected animals, not only in terms of their cellular composition but also by their localization. Even though these nodules invaded haematopoietic organs, i.e. the liver and spleen where they caused a severe splenomegaly, the tumoural syndrome appeared to be considerably amplified in the femoral muscles: the hind limbs of mice infected with 78A1 contained tumours which could reach 500 mg.
In addition, although mice infected with 78A1 virus had changes in the haematopoietic system, a real myeloproliferative syndrome [as we have described in the case of MPSV-induced neoplasia ] was not observed in these animals. A severe anaemia and a hyperleukocytosis were observed in the peripheral blood, primarily related to an increased number of mature granulocytes, and not to the presence of circulating blast cells. In addition, this leukocytosis (15000 white blood cells per ml) never reached the level observed in MPSV mice, where the number of nucleated cells can reach 50000 to 70000 per ml in the terminal phase of the disease. It is nevertheless difficult to compare the terminal phase of the 78A1 virusinduced syndrome to that of the MPSV-induced disease, since mice infected with 78A1 are afflicted relatively rapidly by a paralysis which kills them within a few days. Such hind leg paralysis has previously been observed in MPSV-infected mice (Chirigos et al., 1968 ; M. C. Le Bousse-Kerdiles, unpublished results). In our study, we show that this paralysis is due to the cloned 78A1 virus and not to the associated helper . At present, 78A 1 virus is the only cloned sarcoma virus which has been found capable of inducing such a paralysis. Recently, DesGroseillers et al. (1984) have cloned a retrovirus, initially isolated from the brain of a paralysed wild mouse, which is able to induce hind leg paralysis, but this virus was an ecotropic MuLV.
The number of nucleated cells and granulo-macrophagic precursors in the femoral bone marrow of 78A1 mice underwent an important decrease, but we observed no myelofibrosis characteristic of myeloproliferative syndromes. It is possible that this decrease of marrow cells has a different cause from that described in MPSV-induced neoplasia. Thus, the decreased number of femoral marrow cells observed in MPSV-infected animals is not a reflection of an authentic aplasia, but seems to result from the technical difficulty encountered in recovering marrow cells imprisoned in the dense reticulin fibre network. In mice infected with 78A1 virus, on the other hand, histological investigations have shown a medullary aplasia concomitant with a considerable increase in the number of fat cells. This situation in these animals could thus be a genuine decrease of marrow haematopoiesis, due either to the death or the migration of haematopoietic precursors. The considerable decrease of cell and GM-CFC numbers we observed in normal bone marrow cultures infected with 78A1 in vitro is an argument in favour of the hypothesis of cell death. This type of inhibition of haematopoiesis in vitro has been previously described after infection of normal marrow cultures with sarcoma viruses (Greenberger, 1979) . Thus, the action of 78A 1 in vitro appears to be comparable to that of other sarcoma viruses, but it differs from the effect of MPSV, which stimulates haematopoiesis in vitro (Mori et al., 1983) .
The concentration of GM-CFC in the spleen increased by a factor of five, but this increase does not seem to be specifically caused by the effect of 78A1 virus, since it was also observed in mice infected with HT1 or with Mo-MuLV viruses. Taking into account the considerable splenomegaly of mice infected with 78A1 virus (spleen weight l0 to 15 times greater than normal), the total number of GM-CFC per spleen was in fact 50 to 75 times higher than normal. This increase in the splenic GM-CFC compartment was nevertheless lower than that observed in spleens of MPSV-infected animals, where the total number of GM-CFC was multiplied by a factor of 100 to 150 and their concentration by a factor of D0 (Klein et al., 1981) .
Finally, we were able to demonstrate the specific presence in the spleens of 78A1-infected mice of GM-CFC whose growth in vitro did not require the addition of stimulatory factor. These cells were not observed after infection with HT1 or Mo-MuLV. The appearance of GM-CFC CSF-in the spleen is one of the characteristics of MPSV-induced neoplasia (Klein et al., 1982) . We have recently shown that GM-CFC CSF-in this neoplasia are encountered primarily in the tumour nodules located in the spleen and on the peritoneum (F. Smadja-Joffe, unpublished results). It is then pertinent to address the question whether the same is true in the splenic tumour nodules of mice infected with 78A1 virus.
In conclusion, when the 78A1 virus is injected i.v., it shows (as with MPSV) a tropism for the spleen, liver and non-haematopoietic organs, where it leads to the appearance of tumour nodules. This property distinguishes it from the HT1 Mo-MuSV, ano is not due to the action of the helper virus, MoMuLV. In contrast to MPSV, however, 78A1 virus does not induce a genuine myeloproliferative syndrome. This different effect of 78A 1 on haematopoiesis might be due to subtle differences in the genomic structures of these two viruses.
